Insider filing · AUPH
Peter Greenleaf
Chief Executive Officer
profile →
Aurinia Pharmaceuticals Inc.
AUPH · Healthcare · 12 filings in 24 months
ticker →
Peter Greenleaf sold $2.9M of Aurinia Pharmaceuticals (AUPH)
Executed Mar 3 2025, disclosed Mar 4 2025, 1 day later.
Value, as filed
$2.9M
360,540 sh across 2 lots
Executed
Mar 3 2025
the trade date, as filed
Disclosed
Mar 4 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PGPeter Greenleaf (Chief Executive Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Aurinia Pharmaceuticals Inc. (AUPH). The largest single filing was $2.9M of AUPH (360,540 sh across 2 lots, as filed), executed Mar 3 2025.
The name
AUPHHealthcare · Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with h…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→